Corvus Pharmaceuticals, Inc. (CRVS)
16.74
+1.70
(+11.30%)
USD |
NASDAQ |
Apr 17, 16:00
16.84
+0.10
(+0.60%)
After-Hours: 20:00
Corvus Pharmaceuticals Cash from Investing (Quarterly) : 10.88M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Plus Therapeutics, Inc. | -1.077M |
| Geron Corp. | 21.14M |
| Nektar Therapeutics | 0.372M |
| Jaguar Health, Inc. | 0.013M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.191M |
| Cash from Financing (Quarterly) | 0.02M |
| Free Cash Flow | -32.97M |
| Free Cash Flow Per Share (Quarterly) | -0.1111 |
| Free Cash Flow to Equity (Quarterly) | -9.142M |
| Free Cash Flow to Firm (Quarterly) | -9.216M |
| Free Cash Flow Yield | -2.47% |